Deucravacitinib Inhibits Synovial Fibroblast Activation Via TYK2/STAT3 and PI3K/Akt Signaling Pathway
Inflammation · 11.03.2026 · 49 (1)
DOI: 10.1007/s10753-026-02488-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, online erschienen am 11.03.2026. Verfasst von Zechao Qu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, TYK2 Kinase, Fibroblasts, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China, Medical Research Project of Xi'an Science and Technology Bureau, he Shaanxi Province Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
- Department of Rheumatology and Immunology, First Affiliated Hospital of Xi'an JiaoTong University, Xi'an, 710061, China.
- School of Medicine, Northwest University, Xi'an, 710069, China.
- Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China. yanliangdr5583@163.com.
- Department of Rheumatology and Immunology, First Affiliated Hospital of Xi'an JiaoTong University, Xi'an, 710061, China. wudui220@163.com.
Förderung
- the National Natural Science Foundation of China
- Medical Research Project of Xi'an Science and Technology Bureau
- he Shaanxi Province Natural Science Foundation
- First Affiliated Hospital of Xi'an JiaoTong University Foundation
- Medical Research Project of Xi’an Science and Technology Bureau
- First Affiliated Hospital of Xi’an JiaoTong University Foundation
Zitieren
APA
Qu, Z., Wang, J., Wang, X., Mo, L., Li, H., Liu, X., Chai, X., Yan, L., & Li, Y. (2026). Deucravacitinib Inhibits Synovial Fibroblast Activation Via TYK2/STAT3 and PI3K/Akt Signaling Pathway. Inflammation, 49(1). https://doi.org/10.1007/s10753-026-02488-5
Vancouver
Qu Z, Wang J, Wang X, Mo L, Li H, Liu X, et al. Deucravacitinib Inhibits Synovial Fibroblast Activation Via TYK2/STAT3 and PI3K/Akt Signaling Pathway. Inflammation. 2026;49(1). doi:10.1007/s10753-026-02488-5
BibTeX
@article{Qu2026,
author = {Qu, Zechao and Wang, Jing and Wang, Xiaohao and Mo, Lingfei and Li, Hanchao and Liu, Xinyi and Chai, Xiawei and Yan, Liang and Li, Yuanyuan},
title = {Deucravacitinib Inhibits Synovial Fibroblast Activation Via TYK2/STAT3 and PI3K/Akt Signaling Pathway},
journal = {Inflammation},
year = {2026},
volume = {49},
number = {1},
doi = {10.1007/s10753-026-02488-5}
}
EUVIMED